Published in Eur J Nucl Med Mol Imaging on December 18, 2010
Nanoparticle-based monitoring of cell therapy. Nanotechnology (2011) 1.01
Photostable fluorescent organic dots with aggregation-induced emission (AIE dots) for noninvasive long-term cell tracing. Sci Rep (2013) 1.00
Antigen-loaded dendritic cell migration: MR imaging in a pancreatic carcinoma model. Radiology (2014) 0.89
In vivo Tracking of Dendritic Cell using MRI Reporter Gene, Ferritin. PLoS One (2015) 0.84
Reporter gene imaging of immune responses to cancer: progress and challenges. Theranostics (2012) 0.83
In vivo monitoring of natural killer cell trafficking during tumor immunotherapy. Magn Reson Insights (2014) 0.83
In vivo non invasive molecular imaging for immune cell tracking in small animals. Immune Netw (2012) 0.82
Near-infrared imaging of adoptive immune cell therapy in breast cancer model using cell membrane labeling. PLoS One (2014) 0.82
High-field small animal magnetic resonance oncology studies. Phys Med Biol (2013) 0.81
Current Perspectives in Mesenchymal Stromal Cell Therapies for Airway Tissue Defects. Stem Cells Int (2015) 0.81
Whole-body imaging of adoptively transferred T cells using magnetic resonance imaging, single photon emission computed tomography and positron emission tomography techniques, with a focus on regulatory T cells. Clin Exp Immunol (2013) 0.78
Altered reward circuitry in the norepinephrine transporter knockout mouse. PLoS One (2013) 0.78
Advances in Molecular Imaging Strategies for In Vivo Tracking of Immune Cells. Biomed Res Int (2016) 0.77
Current Perspectives on In Vivo Noninvasive Tracking of Extracellular Vesicles with Molecular Imaging. Biomed Res Int (2017) 0.75
Characterization of the Tumor Microenvironment and Tumor-Stroma Interaction by Non-invasive Preclinical Imaging. Front Oncol (2017) 0.75
Dendritic cells and the control of immunity. Nature (1998) 56.54
Inflammation and cancer. Nature (2002) 53.78
Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science (1993) 19.80
Semiconductor nanocrystals as fluorescent biological labels. Science (1998) 16.68
Dendritic cells: specialized and regulated antigen processing machines. Cell (2001) 10.44
Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med (2001) 9.99
Surrogate end points in clinical trials: are we being misled? Ann Intern Med (1996) 9.81
A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res (2004) 7.56
Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med (1998) 7.48
Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed (2004) 6.94
Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res (2007) 6.60
Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol (2005) 5.80
Cytotoxicity of nanoparticles. Small (2008) 5.63
Dynamic imaging of T cell-dendritic cell interactions in lymph nodes. Science (2002) 5.61
In vivo imaging platform for tracking immunotherapeutic cells. Nat Biotechnol (2005) 5.49
Cell-specific targeting of nanoparticles by multivalent attachment of small molecules. Nat Biotechnol (2005) 5.19
Luminescent quantum dots for multiplexed biological detection and imaging. Curr Opin Biotechnol (2002) 4.93
Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood (2004) 4.66
Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. Cancer Res (2007) 4.39
Regulation of T cell immunity by dendritic cells. Cell (2001) 4.38
Multiphoton microscopy in life sciences. J Microsc (2000) 4.12
Molecular imaging in drug development. Nat Rev Drug Discov (2008) 4.06
DC-based cancer vaccines. J Clin Invest (2007) 3.81
Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity. Cancer Res (2001) 3.51
The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. Immunol Rev (2008) 3.33
Distinct T cell dynamics in lymph nodes during the induction of tolerance and immunity. Nat Immunol (2004) 3.25
Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors. J Exp Med (2005) 3.01
Inhibition of myeloid cell differentiation in cancer: the role of reactive oxygen species. J Leukoc Biol (2003) 2.94
In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor. J Exp Med (2007) 2.89
Migration patterns of dendritic cells in the mouse. Traffic from the blood, and T cell-dependent and -independent entry to lymphoid tissues. J Exp Med (1988) 2.73
Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes. Proc Natl Acad Sci U S A (2004) 2.70
Noninvasive detection of therapeutic cytolytic T cells with 18F-FHBG PET in a patient with glioma. Nat Clin Pract Oncol (2008) 2.61
Random migration precedes stable target cell interactions of tumor-infiltrating T cells. J Exp Med (2006) 2.43
In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors. Cancer Res (2003) 2.12
T-cell activation by dendritic cells in the lymph node: lessons from the movies. Nat Rev Immunol (2008) 2.10
Indium-111-labeled autologous leukocytes in man. J Nucl Med (1977) 2.10
Inflammatory cell infiltration of tumors: Jekyll or Hyde. Cancer Metastasis Rev (2007) 1.99
Guided by the light: visualizing biomolecular processes in living animals with bioluminescence. Curr Opin Chem Biol (2009) 1.97
High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer. Cancer Res (2007) 1.96
On the cyto-toxicity caused by quantum dots. Microbiol Immunol (2004) 1.90
The role of tumor stroma in the interaction between tumor and immune system. Curr Opin Immunol (2005) 1.89
Mapping transplanted stem cell migration after a stroke: a serial, in vivo magnetic resonance imaging study. Neuroimage (2004) 1.86
Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regression. Cancer Res (2001) 1.82
Tracking transplanted stem cell migration using bifunctional, contrast agent-enhanced, magnetic resonance imaging. Neuroimage (2002) 1.82
Fluorocarbons and fluorinated amphiphiles in drug delivery and biomedical research. Adv Drug Deliv Rev (2001) 1.69
IL-12 rapidly alters the functional profile of tumor-associated and tumor-infiltrating macrophages in vitro and in vivo. J Immunol (2007) 1.67
Validity of bioluminescence measurements for noninvasive in vivo imaging of tumor load in small animals. Biotechniques (2007) 1.66
In vivo imaging of T cell delivery to tumors after adoptive transfer therapy. Proc Natl Acad Sci U S A (2007) 1.65
Labeling of immune cells for in vivo imaging using magnetofluorescent nanoparticles. Nat Protoc (2006) 1.63
A closer look at homeostatic proliferation of CD4+ T cells: costimulatory requirements and role in memory formation. J Immunol (2001) 1.39
Monitoring the efficacy of adoptively transferred prostate cancer-targeted human T lymphocytes with PET and bioluminescence imaging. J Nucl Med (2008) 1.35
In vivo magnetic resonance imaging of dendritic cell migration into the draining lymph nodes of mice. Eur J Immunol (2006) 1.31
Molecular mechanisms of MHC class I abnormalities and APM components in human tumors. Cancer Immunol Immunother (2008) 1.31
Assessing responses to cancer therapy using molecular imaging. Biochim Biophys Acta (2006) 1.31
Behavior of endogenous tumor-associated macrophages assessed in vivo using a functionalized nanoparticle. Neoplasia (2009) 1.28
A near-infrared cell tracker reagent for multiscopic in vivo imaging and quantification of leukocyte immune responses. PLoS One (2007) 1.26
Macrophage-derived angiogenesis factors. Pharmacol Ther (1991) 1.26
Fluorescent labeling of endoplasmic reticulum. Methods Cell Biol (1989) 1.24
Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients. Clin Cancer Res (2009) 1.24
Functional assessment of human dendritic cells labeled for in vivo (19)F magnetic resonance imaging cell tracking. Cytotherapy (2010) 1.23
Effects on in vitro tumor growth of murine macrophages isolated from sarcoma lines differing in immunogenicity and metastasizing capacity. Int J Cancer (1978) 1.22
Dendritic cell maturation is required for initiation of the immune response. J Leukoc Biol (1997) 1.22
Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells. Proc Natl Acad Sci U S A (1995) 1.20
Viral vectors: from virology to transgene expression. Br J Pharmacol (2009) 1.19
MRI reporter genes. J Nucl Med (2008) 1.19
Surface functionalized hollow manganese oxide nanoparticles for cancer targeted siRNA delivery and magnetic resonance imaging. Biomaterials (2011) 1.18
In vivo imaging and quantitation of adoptively transferred human antigen-specific T cells transduced to express a human norepinephrine transporter gene. Cancer Res (2007) 1.15
Local administration of dendritic cells inhibits established breast tumor growth: implications for apoptosis-inducing agents. Cancer Res (2001) 1.14
Innate immune response induced by gene delivery vectors. Int J Pharm (2007) 1.11
IFN-gamma induces apoptosis in ovarian cancer cells in vivo and in vitro. Clin Cancer Res (2003) 1.11
Monitoring the antitumor response of naive and memory CD8 T cells in RAG1-/- mice by positron-emission tomography. J Immunol (2006) 1.09
Use of fluorescent quantum dot bioconjugates for cellular imaging of immune cells, cell organelle labeling, and nanomedicine: surface modification regulates biological function, including cytotoxicity. J Artif Organs (2007) 1.08
Evaluation of in vivo labelled dendritic cell migration in cancer patients. J Transl Med (2004) 1.08
Imaging the choreography of lymphocyte trafficking and the immune response. Curr Opin Immunol (2006) 1.07
Imaging immune response in vivo: cytolytic action of genetically altered T cells directed to glioblastoma multiforme. Clin Cancer Res (2008) 1.06
Small animal imaging. current technology and perspectives for oncological imaging. Eur J Cancer (2002) 1.05
In vivo cellular imaging of lymphocyte trafficking by MRI: a tumor model approach to cell-based anticancer therapy. Magn Reson Med (2006) 1.03
111In-oxine and 99mTc-HMPAO labelling of antigen-loaded dendritic cells: in vivo imaging and influence on motility and actin content. Eur J Nucl Med Mol Imaging (2003) 0.98
Functional studies in living animals using multiphoton microscopy. ILAR J (2008) 0.98
Effect of optical tissue clearing on spatial resolution and sensitivity of bioluminescence imaging. J Biomed Opt (2006) 0.97
In vivo tracking of dendritic cells in patients with multiple myeloma. J Immunother (2008) 0.96
Fluorine-18 labeled mouse bone marrow-derived dendritic cells can be detected in vivo by high resolution projection imaging. J Immunol Methods (2002) 0.95
Noninvasive imaging of dendritic cell migration into lymph nodes using near-infrared fluorescent semiconductor nanocrystals. FASEB J (2008) 0.94
The expression level of luciferase within tumour cells can alter tumour growth upon in vivo bioluminescence imaging. Luminescence (2007) 0.94
Convertible manganese contrast for molecular and cellular MRI. Magn Reson Med (2008) 0.94
Cytotoxicity of 111In-oxine on mesenchymal stem cells: a time-dependent adverse effect. Nucl Med Commun (2009) 0.93
The tumor enhancement phenomenon: reinterpretation from a Th1/Th2 perspective. J Natl Cancer Inst (1996) 0.93
Molecular imaging of cell-mediated cancer immunotherapy. Trends Biotechnol (2006) 0.92
Macrophages transduced with an adenoviral vector expressing interleukin 12 suppress tumor growth and metastasis in a preclinical metastatic prostate cancer model. Cancer Res (2003) 0.91
Molecular imaging: a new way to study molecular processes in vivo. Mol Cell Endocrinol (2006) 0.91
Dendritic-cell- and peptide-based vaccination strategies for glioma. Neurosurg Rev (2009) 0.90
Assessing cell trafficking by noninvasive imaging techniques: applications in experimental tumor immunology. Q J Nucl Med Mol Imaging (2005) 0.89
Dendritic cells: therapy and imaging. Expert Opin Biol Ther (2009) 0.89
Divergent effects of macrophage toxins on growth of primary tumors and lung metastases in mice. Int J Cancer (1980) 0.88
Exploiting dendritic cells for active immunotherapy of cancer and chronic infections. Mol Biotechnol (2007) 0.87
Biodistribution of radiolabelled human dendritic cells injected by various routes. Eur J Nucl Med Mol Imaging (2005) 0.86
Effect of a perfluorocarbon emulsion (Fluosol-DA) on reticuloendothelial system clearance function. Am J Hematol (1984) 0.86
Ex vivo expanded dendritic cells home to T-cell zones of lymphoid organs and survive in vivo after allogeneic bone marrow transplantation. Am J Pathol (2005) 0.86
Autologous human macrophages and anti-tumour cell therapy. Res Immunol (1999) 0.84
Interferon-gamma reduces Ia+ dendritic cell traffic to the lung. J Leukoc Biol (1996) 0.84
Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias. J Nucl Med (2008) 2.92
B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression. Blood (2002) 2.17
Probiotics reduce gut microbial translocation and improve adult atopic dermatitis. J Clin Gastroenterol (2012) 2.15
The 'immunologic advantage' of HIV-exposed seronegative individuals. AIDS (2009) 2.15
Parasites represent a major selective force for interleukin genes and shape the genetic predisposition to autoimmune conditions. J Exp Med (2009) 2.00
Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease. Mult Scler (2012) 1.77
Profile of the circulating DNA in apparently healthy individuals. Clin Chem (2009) 1.61
Hiv-specific secretory IgA in breast milk of HIV-positive mothers is not associated with protection against HIV transmission among breast-fed infants. J Pediatr (2006) 1.61
Early impairment of gut function and gut flora supporting a role for alteration of gastrointestinal mucosa in human immunodeficiency virus pathogenesis. J Clin Microbiol (2007) 1.60
Low-dose prolonged intermittent interleukin-2 adjuvant therapy: results of a randomized trial among human immunodeficiency virus-positive patients with advanced immune impairment. J Infect Dis (2002) 1.52
Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects. J Acquir Immune Defic Syndr (2002) 1.45
Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders. Blood (2011) 1.42
Distinct cytokine patterns associated with different forms of chronic dysimmune neuropathy. Muscle Nerve (2010) 1.41
Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART. AIDS (2006) 1.40
Hybrid versus fusion imaging: are we moving forward judiciously? Eur J Nucl Med Mol Imaging (2010) 1.39
IL-22 participates in an innate anti-HIV-1 host-resistance network through acute-phase protein induction. J Immunol (2007) 1.35
Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G: a possible role in the resistance to HIV of HIV-exposed seronegative individuals. J Infect Dis (2007) 1.33
Atherosclerosis is associated with multiple pathogenic mechanisms in HIV-infected antiretroviral-naive or treated individuals. AIDS (2013) 1.29
Performance evaluation of the new whole-body PET/CT scanner: Discovery ST. Eur J Nucl Med Mol Imaging (2004) 1.28
PDL-1 upregulation on monocytes and T cells by HIV via type I interferon: restricted expression of type I interferon receptor by CCR5-expressing leukocytes. Clin Immunol (2008) 1.28
Immune activation, apoptosis, and Treg activity are associated with persistently reduced CD4+ T-cell counts during antiretroviral therapy. AIDS (2010) 1.26
Sentinel lymph node detection following the hysteroscopic peritumoural injection of 99mTc-labelled albumin nanocolloid in endometrial cancer. Eur J Nucl Med Mol Imaging (2004) 1.25
Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection. Antivir Ther (2009) 1.20
Antiretroviral therapy-associated modulation of Th1 and Th2 immune responses in HIV-infected pregnant women. J Reprod Immunol (2006) 1.16
Mucosal and systemic HIV-1-specific immunity in HIV-1-exposed but uninfected heterosexual men. AIDS (2003) 1.13
Alpha-defensins in the prevention of HIV transmission among breastfed infants. J Acquir Immune Defic Syndr (2005) 1.12
Probiotics and health: an evidence-based review. Pharmacol Res (2011) 1.12
Protease inhibitor-associated increased risk of preterm delivery is an immunological complication of therapy. J Infect Dis (2007) 1.10
Treatment of periodontal disease results in improvements in endothelial dysfunction and reduction of the carotid intima-media thickness. FASEB J (2008) 1.10
Genetic diversity at endoplasmic reticulum aminopeptidases is maintained by balancing selection and is associated with natural resistance to HIV-1 infection. Hum Mol Genet (2010) 1.08
Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease. Neurobiol Aging (2004) 1.06
Neurocognitive impairment in HIV-infected naïve patients with advanced disease: the role of virus and intrathecal immune activation. Clin Dev Immunol (2012) 1.06
Hemodynamic and autonomic adjustments to real life stress conditions in humans. Hypertension (2002) 1.05
HHV8 a subtype is associated with rapidly evolving classic Kaposi's sarcoma. J Med Virol (2008) 1.05
Population genetics of IFIH1: ancient population structure, local selection, and implications for susceptibility to type 1 diabetes. Mol Biol Evol (2010) 1.05
A common polymorphism in TLR3 confers natural resistance to HIV-1 infection. J Immunol (2011) 1.03
Not just sheer luck! Immune correlates of protection against HIV-1 infection. Vaccine (2007) 1.03
Distinct patterns of HIV-specific memory T lymphocytes in HIV-exposed uninfected individuals and in HIV-infected patients. AIDS (2005) 1.02
Immune profiles of patients with chronic idiopathic urticaria. Int Arch Allergy Immunol (2002) 1.02
Overactivation of plasmacytoid dendritic cells inhibits antiviral T-cell responses: a model for HIV immunopathogenesis. Blood (2011) 1.01
TLR activation pathways in HIV-1-exposed seronegative individuals. J Immunol (2010) 1.00
Granule-dependent mechanisms of lysis are defective in CD8 T cells of HIV-infected, antiretroviral therapy-treated individuals. AIDS (2004) 1.00
FDG-PET imaging in HIV-infected subjects: relation with therapy and immunovirological variables. Eur J Nucl Med Mol Imaging (2008) 1.00
Individual cerebral metabolic deficits in Alzheimer's disease and amnestic mild cognitive impairment: an FDG PET study. Eur J Nucl Med Mol Imaging (2008) 0.99
The landscape of human genes involved in the immune response to parasitic worms. BMC Evol Biol (2010) 0.99
An autistic endophenotype results in complex immune dysfunction in healthy siblings of autistic children. Biol Psychiatry (2009) 0.98
PD1 negative and PD1 positive CD4+ T regulatory cells in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis (2010) 0.98
Humoral and cellular response to influenza vaccine in HIV-infected children with full viroimmunologic response to antiretroviral therapy. J Acquir Immune Defic Syndr (2008) 0.98
Genotypes at chromosome 22q12-13 are associated with HIV-1-exposed but uninfected status in Italians. AIDS (2005) 0.97
Vitamin D and inflammatory bowel disease. Vitam Horm (2011) 0.96
Failure to eradicate HIV despite fully successful HAART initiated in the first days of life. J Pediatr (2006) 0.96
CD4+ T cell depletion, immune activation and increased production of regulatory T cells in the thymus of HIV-infected individuals. PLoS One (2010) 0.96
Functional repertoire of dendritic cells generated in granulocyte macrophage-colony stimulating factor and interferon-alpha. J Leukoc Biol (2003) 0.95
Inhibition of DC-SIGN-mediated HIV infection by a linear trimannoside mimic in a tetravalent presentation. ACS Chem Biol (2010) 0.95
The hygiene hypothesis: an evolutionary perspective. Microbes Infect (2010) 0.95
Mammalian NPC1 genes may undergo positive selection and human polymorphisms associate with type 2 diabetes. BMC Med (2012) 0.94
The role of protozoa-driven selection in shaping human genetic variability. Trends Genet (2010) 0.94
Genome-wide identification of susceptibility alleles for viral infections through a population genetics approach. PLoS Genet (2010) 0.94
Increased activity of Th-17 and Th-9 lymphocytes and a skewing of the post-thymic differentiation pathway are seen in Alzheimer's disease. Brain Behav Immun (2010) 0.94
A functional variant in ERAP1 predisposes to multiple sclerosis. PLoS One (2012) 0.93
Human alpha defensin in HIV-exposed but uninfected individuals. J Acquir Immune Defic Syndr (2004) 0.93
Under representation of the inhibitory KIR3DL1 molecule and the KIR3DL1+/BW4+ complex in HIV exposed seronegative individuals. J Infect Dis (2011) 0.93
Decrease in pathology and progression of scrapie after immunisation with synthetic prion protein peptides in hamsters. Vaccine (2005) 0.93
Radiation exposure, protection and risk from nuclear medicine procedures. Eur J Nucl Med Mol Imaging (2010) 0.93
Assessing corpus callosum changes in Alzheimer's disease: comparison between tract-based spatial statistics and atlas-based tractography. PLoS One (2012) 0.92
Molecular imaging of cell-mediated cancer immunotherapy. Trends Biotechnol (2006) 0.92
PET/CT in head and neck cancer: an update. Eur J Nucl Med Mol Imaging (2010) 0.91
KIRs and their HLA ligands in remitting-relapsing multiple sclerosis. J Neuroimmunol (2010) 0.91
Modulation of human immunodeficiency virus (HIV)-specific immune response by using efavirenz, nelfinavir, and stavudine in a rescue therapy regimen for HIV-infected, drug-experienced patients. Clin Diagn Lab Immunol (2002) 0.91
Cytokine profiles in schizophrenic patients treated with risperidone: a 3-month follow-up study. Prog Neuropsychopharmacol Biol Psychiatry (2002) 0.90
Peripheral blood endothelial progenitors as potential reservoirs of Kaposi's sarcoma-associated herpesvirus. PLoS One (2008) 0.90
HLA and autoimmune digestive disease: a clinically oriented review for gastroenterologists. Am J Gastroenterol (2009) 0.90
Historical perspective on HIV‐exposed seronegative individuals: has nature done the experiment for us? J Infect Dis (2010) 0.90
Epileptiform activity and cognitive deficits in SNAP-25(+/-) mice are normalized by antiepileptic drugs. Cereb Cortex (2012) 0.89
CCL28 induces mucosal homing of HIV-1-specific IgA-secreting plasma cells in mice immunized with HIV-1 virus-like particles. PLoS One (2011) 0.89
A nonsense polymorphism (R392X) in TLR5 protects from obesity but predisposes to diabetes. J Immunol (2013) 0.89
Balancing selection is common in the extended MHC region but most alleles with opposite risk profile for autoimmune diseases are neutrally evolving. BMC Evol Biol (2011) 0.88
5-HT(2A) receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: a PET study. Psychopharmacology (Berl) (2003) 0.88
A glycomimetic compound inhibits DC-SIGN-mediated HIV infection in cellular and cervical explant models. AIDS (2012) 0.88
CD4+CD25+FoxP3+PD1- regulatory T cells in acute and stable relapsing-remitting multiple sclerosis and their modulation by therapy. FASEB J (2008) 0.88
Costimulatory pathways in multiple sclerosis: distinctive expression of PD-1 and PD-L1 in patients with different patterns of disease. J Immunol (2009) 0.88
A complex proinflammatory role for peripheral monocytes in Alzheimer's disease. J Alzheimers Dis (2014) 0.88
Validation of a new protocol for ¹⁸F-FDG infusion using an automatic combined dispenser and injector system. Eur J Nucl Med Mol Imaging (2012) 0.87
Vitamin D receptor (VDR) gene SNPs influence VDR expression and modulate protection from multiple sclerosis in HLA-DRB1*15-positive individuals. Brain Behav Immun (2011) 0.87
Feasibility of somatostatin receptor scintigraphy in the detection of occult primary gastro-entero-pancreatic (GEP) neuroendocrine tumours. Nucl Med Commun (2004) 0.87
Intrafamiliar transmission of Kaposi's sarcoma-associated herpesvirus and seronegative infection in family members of classic Kaposi's sarcoma patients. J Gen Virol (2011) 0.87
Polycyclic aromatic hydrocarbon exposure and pediatric asthma in children: a case-control study. Environ Health (2013) 0.87
A 175 million year history of T cell regulatory molecules reveals widespread selection, with adaptive evolution of disease alleles. Immunity (2013) 0.87
Titers of herpes simplex virus type 1 antibodies positively correlate with grey matter volumes in Alzheimer's disease. J Alzheimers Dis (2014) 0.86
Preparing for phase II/III HIV vaccine trials in Africa. Microbes Infect (2005) 0.86
Interleukin-2 immunotherapy exerts a differential effect on CD4 and CD8 T cell dynamics. AIDS (2004) 0.86
Cellular magnetic resonance with iron oxide nanoparticles: long-term persistence of SPIO signal in the CNS after transplanted cell death. Nanomedicine (Lond) (2014) 0.86
SNAP-25 single nucleotide polymorphisms are associated with hyperactivity in autism spectrum disorders. Pharmacol Res (2011) 0.86
Evolutionary analysis of the contact system indicates that kininogen evolved adaptively in mammals and in human populations. Mol Biol Evol (2013) 0.86
Techniques: reporter mice - a new way to look at drug action. Trends Pharmacol Sci (2004) 0.86
Current concepts on imaging in radiotherapy. Eur J Nucl Med Mol Imaging (2007) 0.85